Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 2019

View Archived Issues

Novel rat model of multiple system atrophy unresponsive to L-dopa

Botox for -- well, against -- mosquitoes

PTEN and CF

Emmaus Life Sciences screens first patient in phase I diverticulosis study

Enanta initiates phase I study of EDP-514 for the treatment of HBV infection

Promising topline results presented from phase III program of Epsolay in papulopustular rosacea

Pediatric registrational trial of rivogenlecleucel meets primary endpoint

Skyhawk and Merck & Co. to discover and develop novel small molecules that modulate RNA splicing

Novel recombinant R2 pyocin cream for the treatment of P. aeruginosa-infected wounds

Adipokines as potential biomarkers of presence and severity of diabetic retinopathy in T2DM

[86/90Y]DTPA-ALT-836 shows potential in pancreatic cancer theranostics

Autonomic nerve manipulation affects breast cancer progression

Tyme reports phase II data for SM-88 in pancreatic cancer patients with poor prognosis

Zhengzhou University describes Helicobacter pylori-neutrophil activating proteins

Theraphage presents bacteriophage proteins fused to cancer antigens

Lundbeck discovers phosphodiesterase PDE1 inhibitors

New farnesoid X receptor agonists identified at Enanta Pharmaceuticals

Zafgen presents new methionine aminopeptidase 2 inhibitors

Targovax reports part 1 data from study of ONCOS-102 with Keytruda in melanoma

Preliminary data from phase I/II study of Onivyde in first-line pancreatic cancer

Efficacy of SPR-206 against Gram-negative bacteria in murine thigh and lung infection models

Aivita reports new data from ongoing phase II trial of cancer immunotherapy in glioblastoma

Phase III study of camrelizumab in esophageal squamous cell carcinoma meets primary endpoint

Ultra-broad-spectrum beta-lactamase inhibitor QPX-7728 shows early development potential

Primary objective met in PK/PD trial of imeglimin in patients with type 2 diabetes and CKD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...